NCT07263516

Brief Summary

This study investigates whether combining pelvic floor muscle exercises with diaphragmatic breathing exercises can reduce menstrual pain in women with primary dysmenorrhea. Forty participants will be randomly assigned to two groups: one performing both exercises, and the other performing only diaphragmatic breathing. The study will measure pain, menstrual symptoms, quality of life, and psychological well-being before and after the intervention.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Feb 2026Jun 2026

First Submitted

Initial submission to the registry

September 16, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 4, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

February 18, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

September 16, 2025

Last Update Submit

March 15, 2026

Conditions

Keywords

primary dysmenorrheaMenstrual painPelvic floor exercisesDiaphragmatic breathingPhysiotherapyPain managementExercise therapyBiopsychosocial modelDepression, anxiety, stressSleep qualityNon-pharmacological treatmentRandomized controlled trial (RCT)Women's health

Outcome Measures

Primary Outcomes (4)

  • Pain intensity (Visual Analog Scale, VAS)

    Pain severity will be assessed using a 100-mm Visual Analog Scale (VAS), where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Participants will mark their perceived pain level, which will then be measured with a ruler to obtain a numerical value.

    1-2 days before the onset of menstruation (pre-menstrual assessment) and 1-2 days after the end of menstruation (post-menstrual assessment).

  • Pain Threshold (Pressure Algometer)

    Pain threshold will be assessed at six anatomical points using a pressure algometer. Pressure is gradually increased until participants report pain. Two measurements per point are recorded, with the mean value calculated in lbs/cm².

    1-2 days before the onset of menstruation (pre-menstrual assessment) and 1-2 days after the end of menstruation (post-menstrual assessment).

  • Menstrual Symptoms (Menstrual Symptom Scale - MSS)

    The severity of menstrual symptoms will be assessed using the Menstrual Symptom Scale (MSS), whose Turkish validity and reliability were established by Güvenç, Seven, and Akyüz (2014). The scale consists of 22 items, each rated on a 5-point Likert scale from 1 ("never") to 5 ("always"). Minimum possible total score: 22 points Maximum possible total score: 110 points

    1-2 days before the onset of menstruation (pre-menstrual assessment) and 1-2 days after the end of menstruation (post-menstrual assessment).

  • Premenstrual Symptoms (PMS Scale)

    Premenstrual symptoms will be assessed using the 44-item PMS Scale, covering nine subscales such as depressive mood, anxiety, fatigue, irritability, pain, sleep, and appetite changes. The total score of the scale is obtained by summing the scores from all subscales, ranging from 44 to 220 points. Higher scores indicate a greater severity of premenstrual syndrome (PMS) symptoms.

    One week before menstruation

Secondary Outcomes (3)

  • Quality of Life (SF-36)

    1-2 days before the onset of menstruation (pre-menstrual assessment) and 1-2 days after the end of menstruation (post-menstrual assessment).

  • Sleep Quality (Pittsburgh Sleep Quality Index - PSQI)

    1-2 days before the onset of menstruation (pre-menstrual assessment) and 1-2 days after the end of menstruation (post-menstrual assessment).

  • Depression, Anxiety, and Stress (DASS-21)

    1-2 days before the onset of menstruation (pre-menstrual assessment) and 1-2 days after the end of menstruation (post-menstrual assessment).

Study Arms (2)

Arm 1: Intervention group → Pelvic floor + diaphragmatic breathing exercises

EXPERIMENTAL

Participants will perform a combined program of pelvic floor muscle exercises and diaphragmatic breathing exercises. The exercises will be conducted according to the study protocol, with sessions scheduled regularly over the intervention period. Both physical and psychological outcomes will be assessed before and after the menstrual period.

Behavioral: Pelvic Floor + Breathing Exercises

Arm 2: Control group: Diaphragmatic breathing exercises

ACTIVE COMPARATOR

Participants will perform only diaphragmatic breathing exercises according to the study protocol. Assessments of pain, menstrual symptoms, quality of life, sleep quality, and psychological measures will be conducted before and after the menstrual period.

Behavioral: Diaphragmatic Breathing Exercises

Interventions

Participants will perform both pelvic floor and diaphragmatic breathing exercises according to the study protocol. Assessments will focus on pain, quality of life, and psychological measures.

Arm 1: Intervention group → Pelvic floor + diaphragmatic breathing exercises

Participants will perform only diaphragmatic breathing exercises. Assessments will be conducted in the same manner.

Arm 2: Control group: Diaphragmatic breathing exercises

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly individuals who identify as female and have a uterus are eligible to participate.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18 years or older
  • Diagnosed with primary dysmenorrhea (PD)
  • Having regular menstrual cycles for the past 6 months
  • Willing to participate in the study

You may not qualify if:

  • Diagnosis of secondary dysmenorrhea
  • Irregular menstrual cycles (less than 21 days or more than 35 days)
  • History of childbirth or previous pregnancy
  • Currently pregnant
  • Presence of any neurological, systemic, or psychiatric chronic disease
  • Regular use of medications in the past 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Gelişim University

Istanbul, Avcılar, 34310, Turkey (Türkiye)

Location

Related Publications (4)

  • Dixon JS, Bird HA. Reproducibility along a 10 cm vertical visual analogue scale. Ann Rheum Dis. 1981 Feb;40(1):87-9. doi: 10.1136/ard.40.1.87.

  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

  • Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther. 1997 Jan;35(1):79-89. doi: 10.1016/s0005-7967(96)00068-x.

  • ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018 Dec;132(6):e249-e258. doi: 10.1097/AOG.0000000000002978.

MeSH Terms

Conditions

DysmenorrheaAgnosiaDepressionAnxiety DisordersSleep Initiation and Maintenance Disorders

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System DiseasesBehavioral SymptomsBehaviorMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Irmak KARDEŞ

    Istanbul Gelişim University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study. No participants, care providers, investigators, or outcome assessors are blinded to group assignments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to two parallel groups. The intervention group will perform a combined program of pelvic floor muscle and diaphragmatic breathing exercises, while the control group will perform only diaphragmatic breathing exercises. Both groups will be assessed at two time points: before and after the menstrual period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduate Student

Study Record Dates

First Submitted

September 16, 2025

First Posted

December 4, 2025

Study Start

February 18, 2026

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations